• Categories
  • Archives

Showdown Near Between Brazil and AIDS Drugs Labs

The Brazilian government must soon decide about breaking the patents of three antiretroviral medications that are part of the anti-AIDS cocktail.

The decision will probably be made as soon as Minister of Health, Humberto Costa, returns from his trip to Africa, where he is accompanying President Luiz Inácio Lula da Silva.


During this week, the Ministry will still try to negotiate with medicine producers who, almost a month ago, received a government’s request asking for their voluntary license consent, and authorization for the government to produce the medications in Brazil paying for their royalties.


Without identifying the laboratories, the Minister press-service informed that their answers were not very positive. Two out of the three labs contacted by the Minister accept to negotiate, but not under the government’s terms, and the third one does not agree with the proposal.


According to the secretary of Health Protection, Jarbas Barbosa, the volume of resources Brazil spends buying antiretrovirals increases to “unbearable” levels. In 2004, the Ministry spent US$ 217 million (560 million reais) with this type of medication.


According to Barbosa, the government will spend over R$ 349 million (900 million reais) this year, even though the number of new patients has risen only 20%.


“Looking ahead, in two or three years, the situation may negatively affect Brazilian policy for universal access to antiretroviral medication,” he alerts.


Brazil produces only eight of the 16 medications that integrate the anti-AIDS cocktail.


Last March 14th, the Ministry solicited voluntary licensing of three medications: Lopinavir /Ritonavir (Abbot), Efavirenz (Merck Sharp & Dohme), and Tenofovir (Gilead Science Incorporation).


The Ministry of Health affirms that if the laboratories do not accept the proposal, the country may seek compulsory licensing. This mechanism is allowed by the Trade-Related Aspects of Intellectual Property Rights (TRIPS) for cases involving public health.


Agência Brasil

Tags:

  • Show Comments (1)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Qatar Puts Brazilian Bus Company into Road of Success

Company Comil Carrocerias e Onibus (Comil Bodies and Buses), from the city of Erechim ...

Brazil’s Perdigí£o Starts New Unit With and Eye to Europe Tables

Brazilian food company Perdigão is to begin operating a unit in BrasÀ­lia, Brazil’s capital ...

Jordan Gets Zero-Tariff Trade Deal with Brazil and Mercosur

The countries of the Mercosur trading bloc (Brazil, Argentina, Paraguay and Uruguay) signed, during ...

Brazilian Air Force Officer Ending Training for Space Travel

A Brazilian air force officer will become his nation’s first person in space when ...

The Pearl-Qatar Island, a US$ 10 billion project in Doha, Qatar

Brazil Eyes Qatar’s Largest Real Estate Project Ever, an Artificial Island

The largest real estate project in Qatar, The Pearl-Qatar, an artificial island with an ...

Brazil’s Election Board Will Show Parties Expenditures on the Internet

Adding transparency to party funding and standardizing the reporting of party spending. This is ...

Brazil's federal policemen

Brazil’s Operation Arrests 77 and Dismantles Police and Businessmen Gangs

Two politicians, more than a dozen police agents as well as lawyers and businessmen ...

Brazil Sells a Quarter of a Million Light Vehicles in April, a Record

The auto market in Brazil has posted growth of 29.33% in sales of light ...

Inflation Fears Made Brazil Do It

Brazil Central Bank’s Monetary Policy Committee (Copom) decided unanimously to raise the annualized benchmark ...